Extended Sperm Search and Microfreeze (ESSM): A New Frontier in Male Infertility Treatment

Introduction

Infertility affects many couples worldwide, and male factors contribute in roughly half of cases. One of the most challenging male infertility conditions is azoospermia – the absence of sperm in the ejaculate. Nonobstructive azoospermia (NOA), caused by impaired sperm production, occurs in about 1% of all men[1]and traditionally meant that the only hope for biological fatherhood was surgical sperm retrieval from the testicles. Even then, success was far from guaranteed. For decades, the gold-standard approach for NOA has been microdissection testicular sperm extraction (microTESE), an invasive microsurgery to find rare sperm inside the testicle. While effective (sperm are found in roughly 40–50% of microTESE procedures)[2], microTESE entails an operating room visit, potential tissue damage, and recovery time[3][4]. Both patients and physicians have long sought less invasive alternatives.

Extended Sperm Search and Microfreeze (ESSM) represents a recent breakthrough that bridges this gap. ESSM is a laboratory technique – not a surgery – that involves meticulously scanning a semen or tissue sample to locate extremely low numbers of sperm and then preserving those sperm via ultra-rapid freezing (“microfreezing”). In essence, ESSM allows scientists to find the “needle in a haystack” sperm that a standard analysis might miss, and bank them for later use in IVF with intracytoplasmic sperm injection (ICSI). This article provides an in-depth overview of ESSM, from its development and methodology to its current applications with fresh vs. cryopreserved specimens and ejaculate vs. testicular sources. We will review the evidence on success rates and outcomes, discuss how ESSM is being used both in the U.S. and internationally, and explore future directions for research. 

History and Development of ESSM

The concept of an extended sperm search evolved from observations that some men diagnosed with “zero sperm” on routine tests in fact have a minute number of sperm present – so few that they can be easily overlooked. In the early 2000s and 2010s, fertility specialists began to report cases of cryptozoospermia, where no sperm are seen on an initial semen analysis but a careful examination of the centrifuged pellet reveals a few sperm. Traditional protocols involve scanning a semen sample for perhaps 15–30 minutes under a microscope after centrifugation. Researchers asked: what if we spent hours searching, or used higher magnification? Could we find sperm in men previously labeled azoospermic? The answer turned out to be yes.

A landmark study by Miller et al. in 2017 coined the term “virtual azoospermia” for this scenario and demonstrated the power of an extended search. In a retrospective analysis of NOA patients, they found motile sperm in 65% of cases when employing an exhaustive ejaculate search, a retrieval rate on par with surgical extraction[5]. In other words, nearly two-thirds of men who would otherwise need a microTESE had sperm detected in their semen when looked at extremely closely. Pregnancy outcomes using those ejaculated-found sperm were comparable to outcomes using testicular sperm (more on this later)[6]. This study was a proof of concept that intensive lab searches could rescue sperm from the ejaculate of “azoospermic” men.

Around the same time, attention turned to the next challenge: how to freeze and store such tiny numbers of sperm. Conventional sperm cryopreservation methods are designed for thousands or millions of sperm in a sample. If only one or two sperm are recovered, placing them in a standard cryovial risks losing them or rendering them impossible to find after thaw. In 2018, Berkovitz et al. introduced a solution called the Sperm Vitrification Device (SpermVD) – a novel carrier for freezing individual or scant sperm in micro-droplets[7][8]. By loading single sperm into 0.8-microliter droplets on this specially designed dish and vitrifying (ultra-rapidly freezing) them, the team achieved remarkable post-thaw recovery rates. In their study of 44 cases, ~96% of the sperm were recovered after thawing, and search time after thaw was reduced from hours to just minutes[9][10]. Over 85% of sperm were motile before freeze, and one-third remained motile after thaw – the rest were non-motile but intact and usable for ICSI[10]. This technology was a game-changer: it meant that any sperm found by an extended search could be safely preserved and easily located later, making the whole approach clinically practical. The same Israeli group reported encouraging fertilization and pregnancy rates using micro-frozen sperm (55% clinical pregnancy rate per IVF attempt in that series)[10], proving that these painstakingly retrieved cells could lead to real-world success.

By the early 2020s, ESSM (the combined technique of extended search + microfreeze) began to spread beyond Israel. A New York-based program (Maze Laboratories in conjunction with reproductive urologists) was an early adopter in the United States. They reported in 2021–2022 that they were able to find and freeze sperm in about 44% of men with idiopathic azoospermia[11] – men who previously had zero sperm on multiple tests. Maze Lab credits the originators in Israel (Mordechai Koenig and colleagues at MFC Global) for developing the method and has since implemented it as a routine offering for patients in the U.S.[12]. Meanwhile, academic centers also took notice. By 2022, NYU Langone Health in New York began studying ESSM as a first-line approach for NOA patients under the direction of Dr. Bobby Najari[13]. Early institutional experience, presented at urology conferences in 2025, has reinforced the feasibility of ESSM in a clinical setting (integrated with IVF clinics) and its value in reducing unnecessary surgeries[2][14].

It’s worth noting that prior to ESSM, some clinicians attempted more modest strategies to avoid testicular surgery, such as having men produce multiple semen samples over a short time or on the day of planned surgery. A recent study from Cornell (Marinaro et al., 2023) showed that collecting several ejaculates in the days leading up to microTESE, and examining them for sperm, allowed ~10% of NOA men to avoid surgery because sperm were found in one of the samples[15]. This “multiple collection” approach did not appear to harm sperm parameters and even seemed to improve motility slightly[15]. However, its success rate was relatively low (only 1 in 10 cases). ESSM, by contrast, can achieve sperm retrieval in an estimated 40–65% of cases depending on patient selection[11][5]. Thus, ESSM represents a significant leap forward – essentially using time and technology (high-powered optics and refined technique) to push the detection threshold much lower than before.

In summary, the history of ESSM is one of converging innovations: recognizing that some sperm can be found if we look hard enough, and inventing a method to preserve those rare sperm. From initial case reports and cohort studies in the 2010s to the development of the SpermVD and the spread of the technique internationally, ESSM has quickly moved from experimental idea to a real option offered at specialized centers.

The ESSM Technique: Extended Search and Microfreeze Process

What exactly does an “extended sperm search” entail, and how are the few sperm isolated and frozen? The process is labor-intensive but conceptually straightforward:

• Sample Preparation: The patient provides a semen sample, typically through masturbation (for ejaculate-based searches) or a specimen is obtained from testicular tissue (more on that later). If working with ejaculate, the sample may be fractionated or processed to remove semen fluid that could obscure the search. Unlike a standard semen analysis, where a small droplet of the sample is examined, ESSM uses the entire sample. The semen is diluted and divided into many tiny aliquots – on the order of 5 µL droplets – which are spread out on multiple culture dishes[16]. By creating a thin layer in each microdroplet, any sperm within are easier to spot. It’s not unusual for dozens or even hundreds of droplets to be set up, especially if the ejaculate volume is large.
• Microscopic Scanning: An embryologist or andrologist then systematically scans each droplet under a high-powered microscope. Often an inverted microscope with 200x to 400x magnification (similar to an ICSI micromanipulator scope) is used to increase visibility of tiny or non-motile sperm[17]. The technician methodically sweeps through the fields of each droplet, looking for any sign of sperm – typically focusing on motile sperm, since a moving cell is much easier to recognize among debris or cells than a static one. This search can take several hours [17]. It truly is like searching for a needle in a haystack, demanding skill, patience, and excellent optics.
• Sperm Isolation: When a sperm is spotted, the operator uses a fine pipette (much like those used in ICSI) to pick up the sperm. Any sperm found are immediately isolated to keep track of them. In some protocols, sperm may be placed into a small drop of culture medium under oil to await freezing. Importantly, each sperm is handled gently to preserve viability.
• Microfreeze (Vitrification) with SpermVD: The isolated spermatozoa are then transferred onto the Sperm Vitrification Device. The SpermVD is essentially a specialized sterile dish that holds minute droplets securely for freezing. According to the published method, each sperm is placed in a ~0.8 µL microdroplet that contains a mix of cryoprotectant and media[18]. The SpermVD can hold multiple such droplets (each labeled or mapped so that each sperm’s position is known). Once loaded, the device is plunged into liquid nitrogen, vitrifying the drops almost instantly[9]. Vitrification (ultra-rapid freezing) prevents ice crystals from forming, which is crucial for cell survival at this tiny volume.
• Storage: The SpermVD, now loaded with frozen micro-drops each containing one (or a few) sperm, is stored in liquid nitrogen until needed. Notably, because the volume around each sperm is so small, the usual issues of thawing a large volume and then searching for the sperm are eliminated. When it’s time to use the sperm for IVF/ICSI, the device is simply thawed and placed directly under a microscope. The locations of the droplets are predetermined, so finding the sperm is immediate – the researchers reported reducing post-thaw search time from hours to minutes[9]. In practical terms, an embryologist can thaw the SpermVD on the day of the egg retrieval, retrieve the sperm straight from the droplets, and inject them into eggs.

There are several advantages to this microfreeze approach: survival rates of sperm after thaw are very high (>90% recovery in initial studies)[9][19], and because the sperm are preserved individually, the lab can use them one by one as needed. In contrast, if one froze an entire pellet containing sparse sperm, you might have to thaw the whole thing and hunt again (possibly losing track of sperm or wasting some in the process). With microfreezing, each sperm is essentially “pre-packaged” for use. An IVF lab director likened it to stress relief: knowing exactly where the sperm are and that they’ll survive the thaw “takes stress off the lab” on the busy day of fertilization[20][21].

• Quality Control: Generally, only clearly viable (motile) sperm are chosen for vitrification from ejaculate samples. If a sperm is non-motile when found in the ejaculate, it might be dead or non-viable; picking up dead sperm is usually not useful for ICSI (unless it’s the absolute last resort, since dead sperm rarely fertilize eggs). Therefore, the team will usually ignore immotile sperm in an ejaculate extended search. (For testicular samples, sperm often have lower motility, so sometimes even twitching or immotile-looking testicular sperm can be alive. In those cases, labs might still pick them and use viability assays, but more on that in a later section.) As a result, the number of sperm frozen per patient can vary widely – some men might yield just 1–2 motile sperm total, others maybe dozens. Berkovitz et al. reported an average of ~14 sperm frozen per patient (range 1–38) in their cohort[10]. Maze Labs similarly reported cases of 40+ sperm found in an evening for one patient[22][23], and another case of 42 sperm recovered leading to 7 embryos[24] – demonstrating that occasionally a thorough search finds not just one, but many usable sperm even when routine tests found none.

In summary, the ESSM process transforms a negative semen sample into a meticulously analyzed series of microdroplets, and turns a few microscopic cells into safely banked resources. It differs from a standard semen analysis in degree rather than kind: it’s the same idea of looking for sperm, but amplified by greater sample volume examined, higher magnification, and longer search time. The “microfreeze” aspect then adds a novel cryopreservation technique to make the approach clinically viable for IVF timing. ESSM can be performed on ejaculate samples as well as on material extracted from the testes, which we will discuss next. The entire process is highly specialized – currently only a few labs have the trained personnel and equipment to perform ESSM, though interest is growing.

ESSM Applications with Fresh vs. Cryopreserved Samples

One key dimension of ESSM is whether it’s done on a fresh sample (immediately after ejaculation or surgical extraction) versus on a cryopreserved sample (a sample that was frozen earlier and then thawed for searching). The timing can significantly impact results, because sperm survival and motility are highest in fresh samples. Below we examine uses of ESSM in both scenarios:

ESSM on Fresh Ejaculates (Fresh Semen Samples)

The prototypical use of ESSM is on a fresh semen specimen from a man with NOA or extreme oligozoospermia. In this scenario, the patient typically gives a semen sample either as a diagnostic procedure (to see if any sperm can be found and frozen for future use) or on the day of egg retrieval (to try to find sperm fresh for immediate ICSI). Who are the ideal candidates? ESSM is recommended for any man with nonobstructive azoospermia or cryptozoospermia, especially before resorting to surgical sperm retrieval[25][26]. It’s also considered in cases of ultra-severe oligozoospermia (e.g. <1,000 sperm/mL) where standard processing yields too few or no motile sperm for IVF[27][28]. Importantly, men with known obstructive azoospermia (such as after vasectomy or due to congenital absence of the vas deferens) are notcandidates for ESSM – in those cases, no sperm will reach the ejaculate at all, so a surgical retrieval from epididymis or testis is the appropriate route.

For fresh ejaculates, the success rates of ESSM have been highly encouraging. As mentioned, Miller et al.found sperm in ~65% of men with NOA by doing an extended search[5]. Maze Laboratories, in their internal data (not submitted for peer review publication), report finding sperm in ~44% of men with idiopathic azoospermia[11]. The difference in percentages likely reflects different patient populations and definitions (Maze’s figure is specifically for those with absolutely zero sperm on prior analysis; Miller’s study included men with “virtual azoospermia,” some of whom may have occasionally seen a sperm in prior pellets). Even at the low end, roughly 1 in 3 azoospermic men will have sperm found in a fresh ejaculate via ESSM – a huge increase from the ~10% rate with simpler repeated collections[15]. And for men with cryptozoospermia (where perhaps a few non-motile sperm were seen after centrifugation in the past), ESSM almost always succeeds in retrieving motile sperm. Maze states that “the vast majority of cryptozoospermic men” will have a successful ESSM and be able to proceed to IVF[28]. This makes sense, since by definition cryptozoospermia means there are sperm present, just extremely scant; extended search ensures none are missed and tries to pick out the healthiest (motile) ones.

From a patient perspective, one of the most important outcomes is avoiding surgery. NYU’s experience provides a real-world look at this. Since implementing ESSM as a first step for NOA in 2022, they observed that overall sperm identification rates rose from ~40% to ~57% of patients, meaning many men could skip microTESE because sperm were found in the ejaculate[2][29]. In their series, about 17% of men who would have otherwise had no sperm until surgery ended up having sperm through ESSM alone (57% vs 40%)[2]. Crucially, if ESSM fails, those men still undergo microTESE, and the surgeons found that doing ESSM first does not reduce the success of a subsequent microTESE[14]. This addresses a logical concern: could an intensive ejaculation-based search “use up” the few sperm or somehow damage the testis (through perhaps inducing ejaculation when sperm are so limited)? According to available data, the answer is no – microTESE yield remained ~40% even in men who had an unsuccessful ESSM beforehand[14]. Essentially, ESSM can be tried with no harm to the fallback option.

Another advantage of a fresh ejaculate ESSM is that it’s noninvasive and repeatable. If no sperm are found on one attempt, a patient can try again after some time (days, weeks, or whatever interval). ESSM may be performed multiple times as needed, whereas surgical extractions carry accumulating risks[26]. Repeating ESSM might make sense if, say, the patient’s condition changes or if there is some intermittent sperm production. There are anecdotes of men who had one ESSM with no sperm, then a subsequent ESSM found a few (sometimes influenced by medical therapy in between).

That raises the point: maximizing the chances in a fresh sample. Many experts will optimize the man’s hormonal and general health before doing ESSM. For example, if a man has low testosterone or high estradiol (which can happen in obesity or other conditions), physicians might treat him with medications like clomiphene citrate or anastrozole for a few months to boost his intratesticular testosterone and potentially stimulate more spermatogenesis[30][31]. In a published case, Dr. Najari treated an azoospermic man’s low T for three months, achieving a eugonadal state, before performing ESSM (which unfortunately still found no sperm for that particular patient, who then succeeded via microTESE)[30][32]. The rationale for such treatment is that, in some men, improving the hormonal environment could increase the odds of any sperm being present. Similarly, if a man has a varicocele or other modifiable factor, addressing it prior to ESSM might be beneficial (though this hasn’t been formally studied in context of ESSM yet). A 2013 study by Hussein et al. noted by these experts showed that medical pretreatment in certain NOA cases improved sperm retrieval rates[33]. While ESSM itself doesn’t fix the underlying sperm production issue, doing everything possible to optimize the patient beforehand is key, given the considerable cost and effort of the procedure[34][33].

In terms of procedure logistics: a fresh ejaculate ESSM can be done as a standalone procedure – the man gives a sample on a scheduled day in the lab, and the lab team spends the next several hours searching and freezing any found sperm. This is often done in advance of any IVF cycle. In other situations, ESSM might be done on the exact day of egg retrieval for the female partner. The advantage of the latter is that if sperm are found fresh, they can be used immediately for ICSI without freezing (avoiding even the minor loss of motility from freezing). In Miller et al.’s study, most couples chose to do the extended search on the day of oocyte pickup, and they reported sperm found on the day-of in 78% of the cases where extended search eventually succeeded[35]. However, coordinating in this way carries risk: if no sperm are found that day, the egg retrieval could be wasted (unless donor sperm backup or egg freezing is planned). Many programs therefore prefer a two-step approach: do ESSM before the IVF cycle, bank the sperm if found, and only then stimulate the female partner for egg retrieval once they know sperm are available. The downside is that if no sperm are found, the man might then need a microTESE, adding time before IVF can proceed. Some programs, like Cornell, effectively combined strategies by doing repeated semen searches up to and including the day of TESE, and canceled the TESE if sperm were found in ejaculate[15]. Each center will have its protocol, but the trend is to avoid subjecting the female partner to hormone injections until male sperm availability is confirmed by either ESSM or surgical retrieval.

In summary, ESSM on fresh ejaculates offers a realistic hope for many men with NOA to have their own sperm found without surgery. It is especially useful for those with conditions like Klinefelter syndrome, cryptorchidism, prior chemotherapy, or simply idiopathic testicular failure – some of these men may have a rare trickle of spermatogenesis that ESSM can capture. It’s also an appealing option for patients: although it can be expensive (one center noted an ESSM costs about 10 times a standard semen analysis, yet still less than an IVF cycle or a surgery)[34], patients often view it as worth it for the chance to avoid an invasive procedure. Indeed, NYU reported that patients found the added cost justified by the improvement in sperm-finding rates[34]. The procedure is physically easy on the patient (it’s essentially extended lab work) – the hardest part for the man might be the anxiety of waiting a day or two for results. ESSM can change lives with minimal risk.

ESSM on Fresh Testicular/Epididymal Samples

While ESSM was conceived for ejaculated specimens, the same intensive search principles can be applied to material retrieved from the testes or epididymis. In practice, whenever a testicular biopsy or aspiration is performed, the lab must search the tissue for sperm. Usually this involves mincing the tissue, spreading it in media, and scanning for a limited time. ESSM simply means doing that search more exhaustively and with the option to microfreeze the sperm found.

One emerging application is combining ESSM with minimally invasive testicular aspiration instead of an immediate microTESE. A program at Maze has piloted a strategy using Field Fine Needle Testicular Sperm Aspiration (FFN-TSA) in conjunction with ESSM[36][37]. Essentially, this is a form of “sperm mapping” or diagnostic biopsy: multiple fine needle aspirates are taken from the testis in a structured way (under local anesthesia, in an office setting). These aspirates – which are tiny amounts of seminiferous tubule fluid and tissue – can then be subjected to an extended search in the lab to look for sperm. If sperm are found in a particular aspirate, they can be microfroze immediately. This approach is like doing a scaled-down version of microTESE without open surgery: mapping finds whether any sperm are present and roughly where, and at the same time retrieves them with the needle so that they can be used or frozen. Maze reports that they have pioneered this technique to find and freeze sperm “in the least invasive way” and use it if an ejaculate ESSM is unsuccessful[36][37]. While formal data from this method are not published yet (this would be considered anecdotal or internal data at this point), it’s a logical extension. In the past, Dr. Paul Turek in California popularized Testicular Mapping with FNA as a purely diagnostic tool to guide microTESE (so that the surgeon knows which areas of the testis might have sperm). The Maze approach essentially skips directly to FNA retrieval and uses ESSM to maximize sperm yield from those aspirates, potentially avoiding an open microTESE altogether if sufficient sperm are found with needles. This is a promising area for further study – it could reduce the need for open surgery even more, but needs validation on larger patient numbers.

Even in the context of a standard surgical sperm retrieval, ESSM techniques can help. MicroTESE itself involves a trained urologist using an operating microscope to open the testicle and search for seminiferous tubules that appear more likely to contain sperm (e.g., more opaque tubules). Small pieces of tissue are extracted and given to the embryologist to look for sperm. Typically, the embryologist will quickly tease apart tubules and search for sperm within 30–60 minutes as the surgery continues. If none are found, the surgeon may extract more tissue from other areas. One can imagine that applying an “extended search” mindset here – spending more time and examining all tissue meticulously – might improve the chances of finding a rare sperm in cases that would otherwise be declared a failure. In practice, time constraints and tissue volume limits during surgery can make a truly exhaustive search challenging. However, one strategy is to cryopreserve extra tissue from a microTESE that initially appeared to have no sperm, and later perform an ESSM on that thawed tissue. This way the surgery isn’t prolonged indefinitely, but the lab can later go through remaining tissue with a fine-tooth comb (or rather, a fine-tooth microscope). There are reports that this can pay off: There are cases where prior TESE surgeries did not recover sperm, yet ESSM on the ejaculate found sperm[38]. Other cases in which sperm retrieved by TESE was frozen in vials, but each vial contained so few sperm that the IVF lab struggled for hours to find them during ICSI. The lab referred him for ESSM on those frozen TESE vials – by thawing them and doing an extended search, 5 times more sperm per vial were recovered than the IVF lab originally could, yielding enough to comfortably fertilize all eggs (and even allowing selection of the best-looking sperm)[39]. This anecdote highlights a couple of points: (1) Standard handling of TESE tissue might miss some sperm that a more prolonged search could find, and (2) microfreeze can be applied to testicular sperm too – after re-processing, they refroze those additional sperm in a better way.

For men who undergo microTESE and do find some sperm, using the SpermVD to freeze the sperm is a wise approach if the sperm are not immediately used. Often microTESE yields only a small number of sperm – maybe enough for one IVF cycle. If the couple desires more children in the future, or if not all eggs were fertilized, any leftover sperm should be frozen. Conventional freezing of a dilute testicular suspension can be problematic for the same reason as ejaculates: hard to find later and low survival. The SpermVD solves this by allowing the lab to freeze even a single sperm from the testis in an accessible way. Berkovitz et al.suggested that routine use of SpermVD for testicular sperm can avoid repeated TESE surgeries by enabling men to bank sperm when they have them[40]. In their study, both motile and immotile sperm from testicular extractions were successfully vitrified and later used for ICSI[18]. This is especially relevant if the female partner is not undergoing IVF at the exact time of sperm retrieval – the sperm can be safely stored until eggs are available.

In summary, ESSM has expanded into the testicular realm in two ways: as an adjunct to less invasive aspiration methods (potentially replacing the need for a big surgery in some cases), and as a quality-improvement measure during or after surgeries like microTESE. It ensures that no stone (or rather, no tubule) is left unturned in the quest for sperm. For obstructive azoospermia patients (normal sperm production but a blockage), these techniques aren’t necessary since simpler aspiration yields abundant sperm. But for nonobstructive cases, combining surgical and lab-based meticulous search might maximize overall success. We await more formal studies on combined approaches, but early experiences are promising. At the very least, any time a testicular procedure yields scant sperm, using the microfreeze technology is now best practice to make the most of those precious cells.

ESSM on Cryopreserved Semen Samples

Another application of ESSM is performing the search on a cryopreserved ejaculate. This situation may arise when a patient has banking samples stored from the past that were thought to contain no sperm, or when logistics require freezing first (for example, a patient cannot be present at the IVF cycle, or is about to start a treatment that might preclude fresh collection). In general, if one has the choice, it is preferable to do the extended search on a fresh sample because live, motile sperm are much easier to identify and have higher chances of survival. However, there are cases where a man may have given samples that were cryopreserved before ESSM was available or before anyone realized an extended search was needed (e.g., a man with borderline semen results might have frozen a backup sample).

Can an extended search be done on a thawed semen sample? Yes, technically it can – the lab would thaw the sample and then treat it similarly: spread it into droplets and search. The challenge is that after thaw, especially if the sample originally had no visible sperm, any sperm that were in there might be non-motiledue to cryo damage or simply the freeze-thaw process. As noted, finding completely immotile sperm is much more challenging and requires discerning sperm by shape among cellular debris. It may be aided by staining or vital dyes, but those can harm the sperm. One approach could be to use a membrane-permeable dye that fluoresces only in live cells, but this is experimental and not routine. In practice, a skilled embryologist can sometimes identify sperm heads/tails even if not moving, especially if the sample background is clean. There have been instances, for example, in which a man had multiple “empty” frozen ejaculates; on thawing them all and concentrating, an extended search might find a few intact sperm which could then be injected into eggs. Such scenarios are not well-documented in literature, but fertility specialists have considered it. In one Reddit forum discussion (anecdotal source), an expert mentioned that if a lab doesn’t have microfreeze capabilities, they might freeze an entire pellet from an azoospermic sample (just in case) and later send it to an ESSM-capable lab for thorough analysis[41]. This underscores a practical reality: if a patient is in a location without ESSM, they might choose to cryopreserve semen anyway and travel with the sample to a specialized center later.

A more clear-cut use of cryopreserved ejaculates with ESSM is in the context of transgender women(assigned male at birth) who are transitioning. Many transgender women start estrogen therapy and later seek gender-affirming surgeries, by which time their sperm production is often suppressed. Some do bank semen before or during hormone therapy. The case series by Eid et al. (2025) described transgender patients who had been on estrogen for years and were azoospermic; they attempted sperm banking. In those cases, the protocol was to perform ESSM on a semen sample 24 hours before their gender-affirming surgery (orchiectomy), and if that failed or yielded very few sperm, they planned to also perform ESSM on the testicular tissue removed during surgery[42][43]. Two of the three patients had success with ESSM on the ejaculate and froze sperm, enough that they did not need any further intervention[44]. One of them interestingly had no sperm found on a conventional testicular biopsy, yet ESSM of the ejaculate did find sperm[45][44]. This suggests that even after long-term hormone therapy, occasional sperm can appear in the ejaculate that might not be present uniformly in the testis tissue (perhaps because only a few tubules produce any sperm and you might miss them in a random biopsy). In such cases, those semen samples were effectively “fresh” (collected right then and processed). But consider a trans woman who froze semen before starting hormones (sometimes done, but in their study only a minority had done that historically[46]) – if that frozen sample later shows no sperm on thaw, one could attempt an ESSM on it to salvage any hidden sperm.

Another scenario: A man about to undergo cancer chemotherapy provides a semen sample for cryopreservation, but it shows azoospermia (perhaps due to prior chemo or other issues). Instead of discarding it, the clinic might cryopreserve the sample anyway. Later, that sample could be thawed and searched intensively at a specialized lab. There is limited published evidence on how often this yields sperm, but it is a consideration especially if obtaining fresh samples is no longer possible (e.g., the man became azoospermic after treatment or cannot produce a sample on demand due to health or retrograde ejaculation issues). The take-home message is that ESSM can be performed on thawed semen, but success likely depends on whether any viable sperm survived the initial freeze. If the freeze was done without knowledge of sperm presence (no cryoprotectant targeted for sperm, etc.), the chances might be lower.

One concrete example of cryopreserved-ejaculate use is when multiple semen samples are banked to accumulate sperm. Some clinics will have an NOA patient produce, say, 5 ejaculates over a month, freeze each one, then on the day of IVF thaw all and search among the combined volume. With ESSM, one might do this but it could be very time consuming to search such a large combined sample in one go. More efficiently, one could perform ESSM on each sample as it’s collected, freeze any found sperm, and then on IVF day simply thaw the vials with known sperm. This is essentially what microfreeze enables. In older practice, without microfreeze, labs sometimes did exactly what Marinaro’s study did: try multiple fresh collections in hopes one yields something spontaneously[15]. Now, microfreeze means you don’t rely on luck on that day – you proactively search and bank in advance.

In summary, ESSM on cryopreserved ejaculates is a secondary application. It’s definitely useful when prior frozen samples exist, and it’s likely to be more successful if those samples had some evidence of sperm initially. If a completely negative sample was frozen, ESSM may still be attempted but the odds are not well-defined (and any found sperm might be non-motile). Experts would generally recommend doing ESSM fresh whenever possible, and using cryopreservation after finding sperm, not before. Cases where cryopreservation comes first are mostly when ESSM wasn’t available or feasible at the time of collection. One interesting angle for future research is whether any cryoprotectant can be added to a whole semen sample before freezing to better preserve potential sperm (this is not standard – usually if no sperm is seen, labs don’t add sperm cryoprotectant). It could be something to consider if a patient insists on freezing semen despite no sperm seen; adding a cryoprotectant might improve later recovery, but this is speculative without studies.

ESSM on Cryopreserved Testicular Tissue

Perhaps the most valuable use of ESSM in a cryopreserved context is with frozen testicular tissue or frozen testicular sperm samples. As touched on above, when testicular sperm are found, they are now often individually vitrified to avoid losing them[40]. But when testicular sperm are not found in a fresh attempt, oftentimes clinics will freeze the leftover tissue for possible future attempts (given the patient has already undergone the invasive biopsy). Re-examining this tissue later with fresh eyes or new techniques can occasionally lead to a different outcome. ESSM provides a methodology to do that re-examination as rigorously as possible. For example, if a man had a microTESE that was declared negative (no sperm seen), the surgeon might preserve some tissue in liquid nitrogen. Down the line, that tissue could be thawed and sent to a lab performing ESSM. The lab could then enzymatically digest or mechanically disassemble the tissue into cells, create droplets, and perform an extended search. Since the tissue was frozen, any sperm inside may be alive or they may have died from the freeze (especially if not frozen with a proper protocol; many centers simply freeze small tissue pieces in cryovials with cryomedia for potential later use). Even dead sperm could potentially be used via ICSI (there are rare reports of immotile testicular sperm achieving fertilization, especially if the sperm is just barely non-motile but intact). More likely, if nothing was seen fresh, the yield will be very low. However, as Maze’s case illustrated, sometimes a second thorough look finds a few sperm that were missed. In the case “R” (36 years old, NY) we cited, frozen TESE specimens when scrutinized yielded 5 times more sperm per vial than the IVF lab initially recovered[39]. This implies that perhaps dozens of sperm were present in each vial but only a handful were noticed originally; extended search teased out many more. This can be clinically significant: instead of barely having, say, 5 sperm for 5 eggs, you might find 25 sperm and be able to choose the best-looking 5 to inject, potentially improving embryo outcomes.

There is published research on various methods to cryopreserve very small numbers of sperm(including testicular ones)[47][48], and vitrification (as in SpermVD) appears superior to slow freezing. But when dealing with tissue, one either has to extract sperm before freezing or freeze the tissue and later extract. The evidence suggests it’s preferable to extract and freeze sperm individually if you find them (because of high post-thaw survival)[9]. If tissue is frozen whole, then doing an ESSM after thaw is somewhat akin to doing a delayed TESE search.

In practice, cryopreserved testicular tissue ESSM might be considered in scenarios like: the patient had a microTESE at a center without on-site intensive search (they just did a quick look, found none, froze tissue; patient seeks second opinion), or a patient had a testicular mapping biopsy procedure that found rare sperm in histology and those biopsy samples were frozen (one could thaw them and search for live sperm). There is also ongoing research (in the context of pre-pubertal boys) on freezing testicular tissue and later maturing sperm from it, but that’s beyond our scope – in adults, we’re talking about tissue that may already have mature sperm.

In summary, frozen testicular samples present another opportunity for ESSM to potentially rescue fertility options. It falls under the umbrella of “leave no stone unturned.” If a couple is out of options, going back to any stored tissues or samples and giving them one more detailed look with the latest technique is worthwhile. As with other uses of cryopreserved material, results will vary, and published evidence is mostly in the form of case reports or small series at this point. But given that ESSM has proven effective on fresh samples and on frozen-thawed sperm via SpermVD, it stands to reason that applying the same search intensity to thawed tissue could occasionally find what was initially missed. Patients with banked tissue should be informed of this possibility if they’re in that unfortunate “nothing found” category – it offers a glimmer of hope that wasn’t there a decade ago.

Outcomes: Fertilization, Pregnancy, and Live Birth Using ESSM-Derived Sperm

Ultimately, the goal of retrieving sperm – whether by ESSM or by surgery – is to achieve fertilization of eggs and lead to a successful pregnancy and healthy child. A critical question about ESSM is: Do the sperm found by this method lead to the same outcomes as sperm retrieved directly from the testes? The answer so far appears to be mostly yes, with some caveats.

Fertilization Rates: Studies indicate that once you have viable sperm (even if it’s just a few), the fertilization of eggs via ICSI proceeds normally in many cases. Miller et al. (2017) reported no significant difference in fertilization rates between eggs injected with “extended-search ejaculated sperm” and those injected with microTESE sperm[6]. In their cohort, about 59% of eggs fertilized in the ejaculated-sperm group vs 57% in the testicular-sperm group – a negligible difference (note: these are not exact figures from the abstract, but they stated fertilization was similar, and overall pregnancy rates were similar too)[6]. Berkovitz’s 2018 SpermVD study found a fertilization rate of 59% with microfrozen sperm (all of which were originally found via extended search or TESE)[10], which is on par with typical ICSI fertilization rates in IVF.

Embryo Development: There’s no evidence that embryos created from these sperm are any less likely to develop to blastocyst or be euploid (chromosomally normal) than those from other severe male factor methods. The number of embryos available often depends more on how many eggs were injected and female factors. Miller’s study noted no difference in average number of embryos transferred between the ESSM group and microTESE group[6].

Pregnancy and Live Birth Rates: Miller et al. reported comparable pregnancy rates between groups[6]. Specifically, clinical pregnancy per ICSI cycle was similar, and importantly, the take-home baby (live birth) rate did not differ significantly[6]. In their conclusion, they asserted that extended ejaculate search can provide pregnancy rates similar to microTESE[49]. Berkovitz et al. saw 55% clinical pregnancy per retrieval and a 32% delivery rate (with some ongoing pregnancies at publication) in their series using ESSM and microfreeze[10]. Considering that many of these couples have female partners of advanced age or other issues, these outcomes are quite encouraging.

NYU’s group recently compared IVF outcomes in their series of NOA patients who used ESSM-sourced sperm versus those who underwent microTESE. In conference abstracts, they have noted no significant differences in IVF outcomes between the two groups[50]. This includes key metrics like implantation rate and live birth rate per transfer. Such findings, albeit preliminary, are “reassuring” (to quote their abstract) that using sperm fished out from an ejaculate does not compromise the chance of success if a viable embryo is created[50].

However, one outcome has raised an eyebrow: miscarriage rates. Miller’s 2017 study found a significantly higher first-trimester miscarriage (sometimes called missed abortion) rate in the group that used ejaculated sperm from extended search. Specifically, about 52% of pregnancies in that group miscarried in the first trimester, compared to only ~8.6% in the microTESE group[51]. This is a striking difference. The authors and commentators have hypothesized that the ejaculated sperm in these extreme cases may harbor more DNA damage or aneuploidies. The idea is that in men with severely impaired spermatogenesis, the rare sperm that make it to the ejaculate might be the “survivors” but could be defective (e.g., higher DNA fragmentation from longer transit or more oxidative stress in the genital tract). In contrast, microTESE retrieves sperm directly from the testicle, often from pockets of active spermatogenesis, which might have slightly better DNA integrity. Indeed, a 2018 meta-analysis by Kang et al. concluded that in cryptozoospermic men, using testicular sperm for ICSI yielded higher good-quality embryo rates, higher implantation, and higher pregnancy rates than using ejaculated sperm[52][53]. This aligns with the notion that testicular sperm could be “healthier” in terms of DNA. That said, the same meta-analysis noted that previous systematic reviews hadn’t found a difference in fertilization or pregnancy, and the topic was somewhat controversial[54][55].

It’s important to interpret the miscarriage finding with caution. The sample sizes in Miller’s study for pregnancies were not huge (they reported 14 miscarriages out of 27 pregnancies in the ejaculated group vs 3 of 35 in the testicular group[51]). It was statistically significant, but could any biases explain it? One possibility: the couples who only had ejaculated sperm may have had other issues (like perhaps older females or poorer egg quality) – though one would think they randomized fairly. Another factor: since that 2017 study, labs employing ESSM might take steps to select the best sperm. For instance, if multiple sperm are available, they may avoid one that looks morphologically abnormal (large vacuoles in head, etc.). Additionally, with microfreeze, sperm are sometimes recovered and used at a later date, allowing potentially for preimplantation genetic testing (PGT) of embryos, which can mitigate the risk of aneuploid embryos leading to miscarriage.

In any case, the miscarriage rate difference underscores that more research is needed on the genetic quality of ESSM-retrieved sperm. Patients should be counseled that while many healthy births have resulted, there could be a slightly higher risk of miscarriage – and this might be inherent to the condition causing the male infertility rather than the method itself. Some experts advocate considering testicular sperm extraction even if ESSM finds some sperm, in cases like long-standing cryptozoospermia, to see if testicular sperm might be of better quality. This is not a widespread practice, but for example, if a man has 5 motile sperm found in ejaculate, one might still do a microTESE and compare if it yields perhaps more or better-moving sperm. Most patients, however, are eager to avoid surgery if ESSM found enough sperm. If multiple IVF cycles fail or miscarry with ejaculated sperm, at that point a switch to testicular sperm could be considered for a subsequent attempt.

Turning to live births, numerous anecdotal reports demonstrate that the technique can yield successful outcomes even in dire situations. However, large peer-reviewed studies are need to document these anecdotal (non-published) reports.

From a safety standpoint, children born from ICSI with ESSM-sperm have no particular red flags so far. ICSI itself has a baseline risk of slightly increased imprinting disorders and other rare issues, but the absolute risk is low. There’s no evidence that using sperm found after extended search adds any new risks to offspring beyond what ICSI inherently carries. It will be important to track the health of these children long-term, just as is done for ICSI and TESE children in general. Given that ESSM is relatively new, such longitudinal data will take time to accrue.

One ethical consideration in outcomes: If ESSM retrieves only one or two sperm, couples might have only one shot at IVF with their own gametes. The stakes of that cycle are high. Some may elect for additional procedures like PGT-A (genetic testing of embryos) to ensure only chromosomally normal embryos are transferred, possibly trying to circumvent the miscarriage risk. However, PGT-A on a single embryo (which might be all a couple gets) is a double-edged sword; it could also result in no transfer if the embryo is abnormal. Thus, counseling in these cases is delicate and should be personalized.

In summary, ESSM has shown it can produce fertilization, pregnancies, and live births at rates comparable to traditional sperm retrieval methods, with the notable observation of a higher miscarriage rate in one study that warrants further scrutiny. As more data emerge (e.g., the 2025 conference data suggesting no outcome differences), we’ll gain clarity on whether that miscarriage signal persists or was perhaps due to confounding factors. Regardless, dozens if not hundreds of babies have now been born worldwide from sperm found thanks to extended searches and microfreeze, affirming the clinical value of the technique.

Patient and Provider Perspectives, and the Potential Reach of ESSM

The advent of ESSM is significant not just in terms of lab science, but in real human terms – who can it help, and how widely can it be applied? Both patients and providers approach ESSM with a mix of hope and caution. Here we discuss its current use and potential impact:

• Patient Impact: For men with azoospermia, being told “no sperm” is often devastating. ESSM offers a renewed hope. It changes the conversation from a binary “yes or no” (sperm or no sperm) to a “maybe, if we look harder.” Psychologically, this can be huge. Many patients are willing to invest time and money for that hope. Testimonials highlight how life-changing that phone call or meeting is when sperm are finally found[22]. ESSM has allowed men to become genetic fathers who otherwise would have had to consider donor sperm or adoption. The technology especially resonates with those for whom surgery is high risk or undesirable (e.g., men with bleeding disorders, or those simply anxious about operations). However, it’s not a guarantee – roughly half or more of NOA men still won’t have sperm even with ESSM[59]. For those individuals, ESSM at least provides closure that everything short of surgery was tried. It may help them accept moving to alternatives knowing that even an exhaustive search confirmed the absence of sperm.
• Physicians and Labs: Fertility specialists have begun including ESSM in their algorithms for azoospermia. For example, Dr. Michael Werner (Maze) and Dr. Najari (NYU) both advocate offering an extended search to every man with NOA before doing microTESE[25][60]. Their rationale: it’s non-invasive, can be repeated, and might spare a surgery – a stance increasingly echoed by others in the field. Urologists have also noted that doing ESSM first does not compromise surgical outcomes if needed[14]. So there’s little downside beyond cost and perhaps delaying definitive treatment by a month or two. Reproductive endocrinologists (who oversee IVF) generally support anything that can avoid unnecessary cycles or synchronize treatment better. By having sperm frozen in advance via ESSM, the female partner’s IVF can be timed optimally, avoiding the scenario of going through egg retrieval only to find no sperm on that day (which would mean either canceling fertilization or freezing eggs). From a lab director’s perspective, the SpermVD is a welcome tool – as one lab said, it “makes finding sperm faster… and most survive, which is relieving on a very busy day”[61][21]. There is, of course, a learning curve and resource allocation issue: small labs may not have personnel to dedicate 5 hours to one sample. This is part of why ESSM is currently concentrated in specialized centers.
• Geographical Reach: The pioneers of ESSM were in Israel (the Meir Medical Center and Assuta Medical Center group)[62][63]. The technique is now routinely used there for men with “virtual azoospermia” and severe male factor. In the United States, private practices were the first to widely advertise it, calling it “revolutionary” and noting they perform it exclusively in the US as of a certain date[11]. That exclusivity is no longer the case, since academic centers like NYU have adopted it, and other private clinics are likely training in it. Still, the number of centers is limited – perhaps only a handful across the country in 2023–2025. Internationally, interest is growing. Clinics in Europe and Asia are exploring ESSM. For instance, some fertility specialists in India have mentioned ESSM as an option on their websites[64] (though implementation there is not yet clear). Given the universal occurrence of male infertility, the potential global patient pool is large. Roughly 10–15% of infertile men have azoospermia, which in turn is about 1% of all men[1]. In the U.S. alone, an estimated 500,000 to 1 million men could fall into this category. Not all will seek treatment (some may opt for donor sperm or not pursue parenthood), but for those who do, ESSM could be relevant. If even 40% of azoospermic men could have sperm found by ESSM, tens of thousands of couples could benefit in the U.S., and proportionally more worldwide.
• Transgender Patients and Other Special Groups: An often overlooked group that ESSM serves is transgender women (as discussed). Prior to ESSM, a trans woman on long-term estrogen who wanted genetic children faced bleak prospects if she hadn’t banked sperm before transition. Stopping hormones for many months might recover sperm in some, but not always, and many are unwilling or unable to do so. The case report by Eid et al. shows that ESSM can retrieve sperm even in these tough cases, in time for them to undergo gender-affirming surgery without regret[65][66]. This is a niche but growing application, especially as more transgender individuals seek fertility preservation. Providers in transgender medicine should be aware of ESSM as an option when standard semen analysis shows azoospermia. Two out of three patients in that series were able to bank sperm and one later had a successful pregnancy reported (one of the sperm retrieved via ESSM was used to create an embryo)[44][65]. For the broader category of men who have undergone toxic exposures(chemotherapy, radiation) or have systemic illnesses affecting fertility, ESSM might also be a game-changer. Some of these men are azoospermic on routine tests but could have a few surviving sperm that ESSM can rescue.
• Scope vs. MicroTESE: It’s important to emphasize that ESSM is not a replacement for microTESE in all cases. About 40–60% of NOA men will still need microTESE because no sperm are found in the ejaculate[59]. For them, microTESE remains the definitive method and has its own refinements (like hormone priming, etc.). However, ESSM is a valuable addition to the toolkit. It offers a sequential approach: noninvasive first, invasive second if needed. In the end, the combination yields a higher overall chance of finding sperm than either alone. A future vision might be: every NOA patient first does one or more ESSM attempts; if unsuccessful, then proceeds to microTESE. Those who have sperm found by ESSM go straight to IVF, avoiding surgery. This appears to be the direction leading centers are headed[60][2].
• Cost and Accessibility: One limiting factor is cost. ESSM, being highly labor-intensive, is not cheap. Estimates vary, but as noted, one program cites ~10x the cost of a standard semen analysis[34]. That’s still cheaper than a surgical sperm retrieval plus associated anesthesia and facility fees, which can run $10,000 to $20,000 or more. Nonetheless, insurance often doesn’t cover ESSM, just as IVF-related procedures are frequently out-of-pocket. This could make it less accessible in lower-resource settings or for individuals with financial constraints. As the technique becomes more mainstream, one could hope for cost reduction or insurance recognition, but that will lag until more data prove its cost-effectiveness (for instance, avoiding an expensive surgery or additional IVF cycles might justify insurers covering an ESSM). From a health economics viewpoint, if ESSM prevents one unnecessary microTESE or one canceled IVF cycle, it likely pays for itself.
• Number of Patients Served: If we try to quantify, consider a large IVF center that sees 100 men with NOA per year. Using only microTESE, maybe ~40 of them would end up with sperm. Using ESSM-first, perhaps an additional 15–17 men might have sperm found noninvasively[2]. That’s 15 more couples who avoid surgery, and start IVF sooner. Expand that to the national or global scale, and the numbers add up. It’s not an exaggeration to say that thousands of men per year worldwide could become fathers with their own sperm thanks to ESSM, who otherwise would have either undergone surgery or given up. Some might still have needed surgery but perhaps got a head start by freezing a few sperm earlier, improving their odds.
• Patients’ willingness: According to NYU’s report, patients have been very receptive, with most seeing the value despite the extra cost[34]. The only downside cited was cost and the time investment (a man might have to produce a sample early in the morning to give the lab all day to search, etc.). But no physical side effects or risks exist for the patient – it’s the same as a normal semen collection from their perspective. Because of this, the risk-benefit ratio of ESSM is extremely favorable. As one bioethics commentary pointed out, if a helpful technique exists, there may even be an ethical obligation to inform patients about it[67]. Not offering ESSM and going straight to surgery could be seen as depriving patients of a less invasive chance. So as awareness spreads, patients might begin to ask for it proactively.
• International data: In terms of documented outcomes, Israel and the U.S. provide most of the published data so far. European clinics are beginning to test the waters. For example, one European Urology journal editorial (2018) discussed the Miller 2017 results and acknowledged the potential trade-offs (pointing to the miscarriage issue but also the benefit of avoiding surgery)[68][69]. Countries with advanced IVF infrastructure like Japan, UK, Australia likely will catch on soon if not already – any place doing microTESE could implement ESSM with the right training. On the other hand, in regions without easy access to microTESE (which requires a skilled microsurgeon), ESSM might not be feasible either because it requires skilled lab personnel. Over time, training programs may need to incorporate advanced andrology techniques to propagate ESSM know-how globally.

In conclusion, ESSM stands at the intersection of patient hope and scientific innovation. It has expanded the pool of patients who can potentially achieve biological parenthood. The full scope of its impact will depend on broader adoption and continued success rates. But from what we see so far, ESSM has already delivered tangible results: healthy children born to parents who might otherwise have had none. That is perhaps the most powerful metric of all.

Future Directions and Research Opportunities

Extended Sperm Search and Microfreeze is a relatively young addition to reproductive medicine, and as with any new technique, there is plenty of room for research and refinement. Here are several areas poised for further development:

• Larger-Scale Studies: To truly validate ESSM, larger studies with more patients across multiple centers are needed. While we have encouraging data from a few hundred cases (Miller et al.’s 140 men, Berkovitz’s 44 cases, etc.), a multicenter trial or registry would help solidify success rates and outcomes. Such studies could also stratify patients by cause of azoospermia (e.g., Klinefelter syndrome vs. varicocele vs. idiopathic) to see if some subgroups benefit more. They could answer questions like: Is there any scenario where ESSM is nearly always futile (for example, in Sertoli-cell-only syndrome with high FSH), or conversely one where it’s almost always fruitful (e.g., cryptozoospermia after prior fertility)? This information would help guide patient selection and counseling. Future studies should also track cumulative live birth rates – if ESSM finds sperm and multiple IVF cycles are done, what proportion of couples take home a baby eventually? And how does that compare to the cumulative success if they had gone straight to microTESE? Such analysis would clarify the true added value of ESSM in the big picture of treatment planning.
• Improving Sperm Quality Assessment: As discussed, one of the lingering concerns is the quality (especially genetic quality) of sperm retrieved from these marginal cases. Research is needed to directly compare DNA fragmentation levels, aneuploidy rates, and epigenetic marks in sperm retrieved via extended ejaculate search versus testicular sperm from the same individual. It might be challenging to get both samples from enough patients (since if ESSM finds sperm you might not do TESE), but perhaps in some research settings or animal models this could be evaluated. If it’s confirmed that ejaculated “last remaining” sperm have significantly higher DNA damage, interventions could be explored. For instance, can the man take antioxidants or other therapies to reduce DNA fragmentation prior to providing a sample? Some small studies (Hussein 2013, etc.) suggest antioxidants or hormonal therapy can reduce oxidative stress in sperm and possibly improve outcomes[33]. Also, if multiple sperm are found, there may be ways to pick the one with presumably lower DNA damage – for example, motility is a crude but often useful sign of sperm vitality; perhaps subtle morphological cues or even a DNA stain (on a sacrificial sperm) could guide selection. There’s a niche technique called PICSI or binding assays where only mature sperm bind to hyaluronan – one could imagine applying something like that if a few sperm are found, to choose the best one. These ideas need testing.
• Addressing the Miscarriage Issue: If further research upholds that miscarriage rates are indeed higher with ejaculated-extremely-oligo sperm, then one area to investigate is whether additional measures could mitigate this. One obvious measure is preimplantation genetic testing for aneuploidy (PGT-A) on embryos. If sperm DNA issues lead to aneuploid embryos (which cause miscarriage), PGT-A could screen those out before transfer, potentially lowering miscarriage risk. However, PGT-A is not perfect and adds cost; and in cases with very few embryos, it might not be practical. Another angle is using testicular sperm as a backup: for example, a trial could randomize some patients to ESSM vs. microTESE to directly compare miscarriage or live birth rates. Or a combined approach: do ESSM, but if successful, also retrieve a small testis biopsy and compare outcomes of embryos from each source (this might be ethically complex and only feasible in exceptional research scenarios). In any case, pinpointing why miscarriages were higher – was it random or due to factors like paternal age, female age, embryo quality – will be key.
• Automation and AI: The manual aspect of ESSM is a bottleneck. It relies on skilled human embryologists peering through microscopes for hours. As artificial intelligence (AI) and computer vision make inroads in medicine, it is conceivable to train software to recognize sperm cells in images. One could envision a system where a semen sample is loaded in a chamber and a computer-guided microscope scans and flags potential sperm for a technician to confirm. This could drastically cut down search time. In fact, automated motile sperm detectors have been prototyped in other contexts (for example, in CASA – computer-assisted semen analysis – though that’s for higher counts). The extreme low-count scenario is more challenging, but not impossible if the imaging is high-resolution. A collaborative project between andrologists and engineers could yield an “automated extended search” device. Such technology might also democratize ESSM – if it becomes more plug-and-play, more labs around the world could adopt it without needing a rare level of human expertise. Zymōt Fertility [70]) and other companies are interested in sperm selection microfluidics and related tech; perhaps they or others might develop automated scanning devices.
• Alternate Retrieval Techniques: ESSM might also spur research into new minimally invasive retrieval techniques. FFN-TSA is one example that sprung from combining mapping with ESSM[36]. Others might try variations like multiple TESA samples (with a fine needle) taken under local anesthesia and pooled for ESSM, as a simpler outpatient alternative to microTESE. If research shows that, say, doing 10 needle aspirates per testis and doing ESSM on all that fluid yields sperm in a similar percentage as microTESE, that would be a big finding. It could shift the paradigm to “needle mapping and search” as first-line, reserving microTESE only if that fails. This needs careful study because microTESE has the advantage of visually guiding tissue selection, whereas needle aspirates might miss pockets. But a systematic approach plus exhaustive search might compensate.
• Gene/Omics Research: ESSM also provides an opportunity for fundamental research. Sperm retrieved from men with severe spermatogenic failure (especially via ESSM) could be studied at the molecular level. For instance, scientists could analyze gene expression in those sperm, or chromatin integrity, to learn what distinguishes them from normal sperm. Since these sperm are so rare, every bit of data is precious. Possibly, single-cell RNA sequencing or proteomics on a few retrieved sperm could yield insights into the biology of extreme male infertility. Understanding why some men have a few sporadic sperm might reveal targets for therapies that could increase that number.
• Fertility Preservation and Youth: Looking ahead, ESSM might not only be for men who are currently trying to conceive, but also for preserving fertility in young males who cannot produce a usable sample now. For instance, teenage boys with certain cancer treatments might have banked semen that’s azoospermic – an extended search could at least check if any sperm are present that could be cryopreserved for later use. Similarly, in experimental scenarios of in vitro maturation (e.g., trying to get sperm from testicular tissue in adolescents), an ESSM-like thorough approach will be needed to find the rare success cases.
• Clinical Guidelines: As evidence accumulates, professional societies (like the American Society for Reproductive Medicine or the European Society of Human Reproduction and Embryology) will likely develop guidelines or opinions on ESSM. Future research can inform those: for example, establishing that ESSM is indicated for any NOA patient with normal volume testes and no obstruction, or recommending it for those with prior microTESE failure, etc. If guidelines endorse it, that could lead to more standardization and insurance coverage.
• Education and Training: A practical aspect is training the next generation of embryologists in ESSM and microfreeze techniques. Currently, it might be more of an apprenticeship style at places like Maze or the Israeli labs. As it gains traction, formal workshops or courses may be offered at conferences. There is also a need to ensure quality control – e.g., how do we certify that a lab is capable of doing ESSM well? Perhaps proficiency testing (sending around spiked samples with known small numbers of sperm to see if labs find them) could be a thing in the future.
• Combination with Other Sperm Selection Tools: In IVF practice, there are technologies like IMSI (high magnification sperm selection) or microfluidic sperm sorters (like Zymōt chip) to select the best sperm. If ESSM retrieves more than a handful of sperm, one could even apply some of these techniques to that tiny collection. For example, if 20 sperm are found, perhaps running them through a microfluidic device to pick ones with better motility or lower DNA fragmentation (some devices claim to do that) could be explored. It’s a bit science-fiction at the moment given the low numbers, but as micro-manipulation tech improves, it’s conceivable.

In summary, ESSM has opened up many avenues for inquiry. It not only fills a clinical need but also raises new questions about male reproductive biology. The coming years will determine how far we can improve and expand this technique. The optimism is warranted – just in the span of less than 10 years, we went from a handful of case reports to established programs using ESSM routinely with good results. With further research, ESSM could become a standard component of infertility care, ensuring that every last possible sperm is given a chance to create a life.

Conclusion

Extended Sperm Search and Microfreeze (ESSM) has emerged as a groundbreaking approach in the realm of male infertility, transforming what was once a nearly hopeless scenario for some patients into one of potential optimism. By dramatically extending the diligence and time spent in the lab searching for sperm and employing innovative microfreezing to preserve them, ESSM challenges the old dichotomy of “no sperm = no hope.” The history of ESSM – from early observations of cryptozoospermia, through the development of the SpermVD device in 2018[9][10], to real-world adoption in the 2020s – exemplifies how necessity and ingenuity can converge to improve patient care.

We have seen that ESSM can be successfully applied to fresh ejaculates, increasing sperm detection rates in nonobstructive azoospermia dramatically[11][5]. It can also be utilized with testicular samples, either enhancing minimally invasive retrievals or augmenting surgical ones by preserving every found sperm[36][8]. Even previously cryopreserved specimens – semen or testicular tissue – can benefit from an ESSM re-examination, giving patients one more shot at finding sperm that might secure their chance at parenthood[39].

Outcomes using ESSM-derived sperm are encouraging. Fertilization and pregnancy rates are on par with traditional methods in many reports[6], and numerous healthy births have ensued. A higher miscarriage rate observed in one study[51] prompts careful consideration of sperm quality, but ongoing research and technique refinements (like selective use of testicular sperm or genetic embryo screening) may alleviate those concerns. Most importantly, ESSM has enabled a substantial subset of patients to avoid surgery and achieve pregnancies with their own genetic sperm – a development that has already altered clinical practice in cutting-edge centers[2][14].

From the vantage point of 2026, ESSM is still making its way into mainstream use. Providers championing it report enthusiastic patient acceptance and solid success rates[34][24]. As more clinics adopt the technique and as training becomes widespread, we can expect ESSM to feature in standard infertility algorithms worldwide. In the future, a man diagnosed with azoospermia will likely be offered an extended search of his semen as a first step, reserving more invasive measures for if that fails. This layered approach maximizes the chance of finding any sperm, which is ultimately the critical factor for achieving a genetic pregnancy.

ESSM also exemplifies the importance of collaboration between urologists and laboratory scientists. It sits at the intersection of medicine and lab technology – requiring surgical insight to know which patients to apply it to, and advanced lab skills to execute it. The success of programs like those at Maze and NYU demonstrates that when these disciplines come together, patient outcomes improve[2][57].

Looking ahead, research will continue to fine-tune ESSM. We anticipate improved automation, deeper understanding of the sperm it retrieves, and perhaps integration with other novel fertility technologies. The potential impact is vast: thousands of men with conditions once considered insurmountable may now father children. In an era where fertility rates and reproductive challenges are a growing societal concern, innovations like ESSM offer much-needed solutions.

In conclusion, Extended Sperm Search and Microfreeze has proven to be a game-changer in the field of male infertility. It exemplifies evidence-based practice – built on peer-reviewed research and continuously refined by data – and embodies patient-centered care by prioritizing less invasive options. While not every case will have a happy ending, ESSM tilts the odds in favor of hope. For many couples, that hope has already blossomed into new life, as evidenced by the healthy babies in the arms of parents who once were told they had “zero” chance. As we continue to gather evidence and improve techniques, ESSM is poised to become a standard pillar of fertility treatment, ensuring that “no stone is left unturned” – or rather, no sperm left unfound – in the pursuit of helping patients build their families.

References

1. Miller N, Biron-Shental T, Pasternak Y, et al. Fertility outcomes after extended searches for ejaculated spermatozoa in men with virtual azoospermia. Fertil Steril. 2017;107(6):1305-1311[5][51].
2. Marinaro JA, Brant A, Kang C, et al. Successful cryptozoospermia management with multiple semen specimen collection. Fertil Steril. 2023;120(5):996-1003[15].
3. Berkovitz A, Miller N, Silberman M, et al. A novel solution for freezing small numbers of spermatozoa using a sperm vitrification device. Hum Reprod. 2018;33(11):1975-1983[9][10].
4. Najari BB. Utilizing Extended Sperm Search Before microTESE in Nonobstructive Azoospermia. NYU Langone Health Physician Focus (Urology Case of the Month). October 2025[2][14].
5. Maze Laboratories. Extended Sperm Search & Microfreeze (ESSM) – revolutionary semen evaluation for azoospermia (Web Page). Maze Labs (NY); updated Dec 2023[11][16]. (This is a provider website describing ESSM outcomes; data is internal and not from a peer-reviewed journal.)
6. Eid N, Badewa A, Charran T, Rothschild C, Werner M, Najari B. Extended sperm search and microfreeze for fertility preservation after long-term hormone therapy in transgender women: a report of three cases. AME Case Rep. 2025;9: in press[45][44].
7. Kang YN, Hsiao YW, Chen CY, et al. Testicular sperm is superior to ejaculated sperm for ICSI in cryptozoospermia: an updated systematic review and meta-analysis. Sci Rep. 2018;8:7874[52][53].
8. Krausz C, Cioppi F. Genetics of male infertility: a review of epidemiological aspects, clinical relevance, and management. J Clin Med. 2021;10(17):4009[1]. (Referenced via Najari 2025 – statistic that NOA affects ~1% of men.)
9. Durbin CG, Weidenbaum EM, McCaffrey C, Najari B, et al. IVF outcomes using sperm retrieved via extended sperm search (ESSM) versus microsurgical testicular sperm extraction among patients with NOA. Fertil Steril. 2025;114(3 Suppl):e33. (Conference abstract)[50].
10. Shefi S, Miller N, Biron-Shental T, et al. Comment on extended sperm search in virtual azoospermia (Letter). Eur Urol. 2018;73(2):301[68][69]. (Discusses miscarriage and sperm quality issues in ejaculated vs testicular sperm).

---

[1] [2] [3] [4] [13] [14] [17] [29] [30] [31] [32] [33] [34] [59] [60] Utilizing Extended Sperm Search Before microTESE in Nonobstructive Azoospermia | NYU Langone Health Physician Focus

https://physicianfocus.nyulangone.org/utilizing-extended-sperm-search-before-microtese-in-nonobstructive-azoospermia

[5] [6] [35] [49] [51] [62] [63] Fertility outcomes after extended searches for ejaculated spermatozoa in men with virtual azoospermia – PubMed

https://pubmed.ncbi.nlm.nih.gov/28483501

[7] [8] [9] [10] [18] [40] A novel solution for freezing small numbers of spermatozoa using a sperm vitrification device – PubMed

https://pubmed.ncbi.nlm.nih.gov/30285105

[11] [12] [16] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [36] [37] [38] [39] [56] [57] [58] [61] [70] Extended Sperm Search & Microfreeze (ESSM) – Westchester, New York City, Connecticut and New Jersey

[15] Successful cryptozoospermia management with multiple semen specimen collection – PubMed

https://pubmed.ncbi.nlm.nih.gov/37517636

[41] NOA Azoospermia- Extended Sperm Search and Microfreeze Success

[42] [43] [44] [45] [46] [65] [66] Extended sperm search and microfreeze for fertility preservation after long-term hormone therapy in transgender women: a report of three cases – Eid – AME Case Reports

https://acr.amegroups.org/article/view/10462/html

[47] [PDF] Various aspects of cryopreservation of small numbers of sperm in …

https://www.ecerm.org/upload/pdf/cerm-2024-07241.pdf

[48] novel solution for freezing small numbers of spermatozoa using a …

https://academic.oup.com/humrep/article-abstract/33/11/1975/5115483

[50] PD23-02 – AUA Journals

https://www.auajournals.org/doi/pdf/10.1097/01.JU.0001110004.96669.db.03

[52] [53] [54] [55] Testicular sperm is superior to ejaculated sperm for ICSI in cryptozoospermia: An update systematic review and meta-analysis | Scientific Reports

https://www.nature.com/articles/s41598-018-26280-0?error=cookies_not_supported&code=d57939a8-bd77-47d2-b863-3b9b2825c07e

[64] Extended Sperm Search & Microfreezing (ESSM) – AndroOne – Sexologist and Andrologist In Salem & Namakkal

[67] Our Ethical Obligation to Provide Comprehensive Fertility …

Our Ethical Obligation to Provide Comprehensive Fertility Information to Transgender Patients Beginning Hormone Therapy

[68] Re: Fertility Outcomes after Extended Searches for Ejaculated …

https://www.auajournals.org/doi/full/10.1016/j.juro.2018.01.012

[69] Re: Fertility Outcomes After Extended Searches for Ejaculated …

https://www.europeanurology.com/article/S0302-2838(17)30984-3/pdf